Dementia in parkinsonism.
出版信息
Ann Indian Acad Neurol. 2011 Jul;14(Suppl 1):S21-4.
Abstract
摘要
相似文献
1
Dementia in parkinsonism.
Ann Indian Acad Neurol. 2011 Jul;14(Suppl 1):S21-4.
2
Inconsistency between severe substantia nigra degeneration with Lewy bodies and clinical parkinsonism in dementia patients: a cliniconeuropathological study.
Acta Neuropathol. 2000 May;99(5):511-6. doi: 10.1007/s004010051153.
3
The association between parkinsonism, Alzheimer's disease, and mortality: a comprehensive approach.
J Am Geriatr Soc. 2000 Apr;48(4):422-5. doi: 10.1111/j.1532-5415.2000.tb04701.x.
4
A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam.
Mov Disord. 2015 Aug;30(9):1271-5. doi: 10.1002/mds.26264. Epub 2015 Jul 7.
5
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
J Neurol. 2015 Nov;262(11):2498-503. doi: 10.1007/s00415-015-7873-6. Epub 2015 Aug 15.
6
Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex.
J Neurodegener Dis. 2013;2013:679089. doi: 10.1155/2013/679089. Epub 2013 Mar 27.
7
Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
Am J Geriatr Pharmacother. 2012 Dec;10(6):381-9. doi: 10.1016/j.amjopharm.2012.11.001.
8
Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.
JAMA Neurol. 2017 Dec 1;74(12):1431-1438. doi: 10.1001/jamaneurol.2017.2248.
9
Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 25-year prospective case-control study.
Am J Epidemiol. 1986 Oct;124(4):643-56. doi: 10.1093/oxfordjournals.aje.a114437.
10
Parkinsonism in frontotemporal dementias.
Int Rev Neurobiol. 2019;149:249-275. doi: 10.1016/bs.irn.2019.10.012. Epub 2019 Nov 21.
引用本文的文献
1
Insights from a 7-Year Dementia Cohort (VALCODIS): ApoE Genotype Evaluation.
J Clin Med. 2024 Aug 12;13(16):4735. doi: 10.3390/jcm13164735.
2
Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia.
Med Int (Lond). 2023 Jul 4;3(4):34. doi: 10.3892/mi.2023.94. eCollection 2023 Jul-Aug.
本文引用的文献
1
Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
Eur Neuropsychopharmacol. 2007 Feb;17(3):165-71. doi: 10.1016/j.euroneuro.2006.08.007. Epub 2006 Oct 27.
2
Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.
Mov Disord. 2007 Feb 15;22(3):313-8. doi: 10.1002/mds.21116.
3
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Mov Disord. 2006 Dec;21(12):2078-81. doi: 10.1002/mds.21091.
4
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
Mov Disord. 2006 Nov;21(11):1899-907. doi: 10.1002/mds.21077.
5
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
Neurology. 2005 Dec 27;65(12):1863-72. doi: 10.1212/01.wnl.0000187889.17253.b1. Epub 2005 Oct 19.
6
The use of memantine in dementia with Lewy bodies.
J Alzheimers Dis. 2005 Aug;7(4):285-9. doi: 10.3233/jad-2005-7403.
7
Use of ziprasidone in parkinsonian patients with psychosis.
Clin Neuropharmacol. 2005 May-Jun;28(3):111-4. doi: 10.1097/01.wnf.0000164297.91643.ff.
8
Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.
Mov Disord. 2005 Aug;20(8):958-63. doi: 10.1002/mds.20474.
9
Rivastigmine for dementia associated with Parkinson's disease.
N Engl J Med. 2004 Dec 9;351(24):2509-18. doi: 10.1056/NEJMoa041470.
10
Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
Mov Disord. 2005 Jan;20(1):104-5. doi: 10.1002/mds.20260.
Zotero 插件